000 | 01849 a2200541 4500 | ||
---|---|---|---|
005 | 20250515203454.0 | ||
264 | 0 | _c20100525 | |
008 | 201005s 0 0 eng d | ||
022 | _a1651-1980 | ||
024 | 7 |
_a10.3109/00365540903456282 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBang, Didi | |
245 | 0 | 0 |
_aMultidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007. _h[electronic resource] |
260 |
_bScandinavian journal of infectious diseases _cApr 2010 |
||
300 |
_a288-93 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
650 | 0 | 4 | _aBacterial Typing Techniques |
650 | 0 | 4 |
_aCatalase _xgenetics |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDNA Fingerprinting |
650 | 0 | 4 | _aDNA Mutational Analysis |
650 | 0 | 4 |
_aDNA, Bacterial _xgenetics |
650 | 0 | 4 |
_aDNA-Directed RNA Polymerases _xgenetics |
650 | 0 | 4 |
_aDenmark _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aIsoniazid _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xclassification |
650 | 0 | 4 |
_aOxidoreductases _xgenetics |
650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRifampin _xpharmacology |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdrug therapy |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aLillebaek, Troels | |
700 | 1 | _aThomsen, Vibeke Østergaard | |
700 | 1 | _aAndersen, Ase Bengård | |
773 | 0 |
_tScandinavian journal of infectious diseases _gvol. 42 _gno. 4 _gp. 288-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/00365540903456282 _zAvailable from publisher's website |
999 |
_c19459686 _d19459686 |